4//SEC Filing
Guerin Mark Patrick 4
Accession 0001415889-24-017636
CIK 0001130598other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 4:25 PM ET
Size
8.7 KB
Accession
0001415889-24-017636
Insider Transaction Report
Form 4
Guerin Mark Patrick
Chief Accounting Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-06-18−5,500→ 5,500 total→ Common Stock (5,500 underlying) - Exercise/Conversion
Common Stock
2024-06-10+5,500→ 41,476 total - Tax Payment
Common Stock
2024-06-18$0.47/sh−2,221$1,044→ 39,255 total
Footnotes (2)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On June 10, 2022 the reporting person was granted 16,500 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary
Documents
Issuer
Traws Pharma, Inc.
CIK 0001130598
Entity typeother
Related Parties
1- filerCIK 0001607714
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 4:25 PM ET
- Size
- 8.7 KB